Despite limited value of individual tau protein biomarkers in the early diagnosis of PD, the t-tau/t-α-Syn ratio, when combined with t-α-Syn levels in CSF, can greatly increase the accuracy of early PD diagnosis by allowing for better differentiation from AD or DLB (Førland et al., 2020). This evidence concerns the gene MAPT and Parkinson disease.